The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
The pharmacology of bisphosphonates and new insights into their mechanisms of action
Abstract
Bisphosphonates are chemically stable analogs of inorganic pyrophosphate, which are resistant to breakdown by enzymatic hydrolysis. The biological effects of bisphosphonates on calcium metabolism were originally ascribed to their physico-chemical effects on hydroxyapatite crystals. Although such effects may contribute to their overall action, their effects on cells are probably of greater importance, particularly for the more potent compounds. Remarkable progress has been made in increasing the potency of bisphosphonates as inhibitors of bone resorption, and the most potent compounds in current use are characterized by the presence of a nitrogen atom at critical positions in the side chain which, together with the bisphosphonate moiety itself, seems to be essential for maximal activity. As a class the bisphosphonates offer a very effective means of treating Paget's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Self-citationEfficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Self-citationCyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta
Glorieux, F. H., Bishop, N. J., Plotkin, H., Chabot, G., Lanoue, G., & Travers, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391402 · Cited by 1,015
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
Storm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
Diel, I. J., Solomayer, E.-F., Costa, S. D., Gollan, C., Goerner, R., Wallwiener, D., Kaufmann, M., & Bastert, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390601 · Cited by 809
Esophagitis Associated with the Use of Alendronate
de Groen, P. C., Lubbe, D. F., Hirsch, L. J., Daifotis, A., Stephenson, W., Freedholm, D., Pryor-Tillotson, S., Seleznick, M. J., Pinkas, H., & Wang, K. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351403 · Cited by 764
Fleisch, H., Graham, R., Russell, G., & Francis, M. D. (1969) · Science · doi:10.1126/science.165.3899.1262 · Cited by 758
Self-citationGarnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 685
Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Self-citationFrancis, M. D., Graham, R., Russell, G., & Fleisch, H. (1969) · Science · doi:10.1126/science.165.3899.1264 · Cited by 608
Self-citationChavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Effect of Pyrophosphate on Hydroxyapatite and Its Implications in Calcium Homeostasis
FLEISCH, H., RUSSELL, R. G. G., & STRAUMANN, F. (1966) · Nature · doi:10.1038/212901a0 · Cited by 517
Self-citationSchenk, R., Merz, W. A., Mühlbauer, R., Russell, R. G. G., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547219 · Cited by 482
Self-citationBisphosphonates in Bone Disease: From the Laboratory to the Patient
Fleisch, H. A. (1995) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 472
Self-citationMechanisms of calcification: role of collagen, polyphosphates, and phosphatase
Fleish, H., & Neuman, W. F. (1961) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1961.200.6.1296 · Cited by 444
Frith, J. C., Mönkkönen, J., Blackburn, G. M., Russell, R. G. G., & Rogers, M. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1358 · Cited by 437
Self-citationBisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki, A., Boyce, B. F., Story, B. M., Wright, K. R., Chapman, M., Boyce, R. W., Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 417
Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
Green, J. R., Müller, K., & Jaeggi, K. A. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090521 · Cited by 415
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni, M., Guenther, H. L., Fleisch, H., Collin, P., & Martin, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116422 · Cited by 412
Self-citationRegulation of Osteoclast Function
Suda, T., Nakamura, I., Jimi, E., & Takahashi, N. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.869 · Cited by 408
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity
Shipman, C. M., Rogers, M. J., Apperley, J. F., Russell, R. G. G., & Croucher, P. I. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2713086.x · Cited by 398
Self-citationThe binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
Jung, A., Bisaz, S., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547227 · Cited by 381
Self-citationRab GTPases in vesicular transport
Zerial, M., & Stenmark, H. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90130-i · Cited by 381
Adverse Effects of Bisphosphonates: A Comparative Review
Adami, S., & Zamberlan, N. (1996) · Drug Safety · doi:10.2165/00002018-199614030-00003 · Cited by 377
The acute-phase response after bisphosphonate administration
Adami, S., Bhalla, A. K., Dorizzi, R., Montesanti, F., Rosini, S., Salvagno, G., & Lo Cascio, V. (1987) · Calcified Tissue International · doi:10.1007/bf02556671 · Cited by 357
Hughes, D. E., MacDonald, B. R., Russell, R. G., & Gowen, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114100 · Cited by 357
Self-citationProtein Prenylation: a Mediator of Protein-Protein Interactions
Marshall, C. J. (1993) · Science · doi:10.1126/science.8456312 · Cited by 350
Isolation from urine of pyrophosphate, a calcification inhibitor
Fleisch, H., & Bisaz, S. (1962) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1962.203.4.671 · Cited by 349
Self-citationTwo modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Russell, R. G. G., Mühlbauer, R. C., Bisaz, S., Williams, D. A., & Fleisch, H. (1970) · Calcified Tissue Research · doi:10.1007/bf02196199 · Cited by 341
Self-citationFleisch, H. A., Russell, R. G. G., Bisaz, S., Mühlbauer, R. C., & Williams, D. A. (1970) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1970.tb00591.x · Cited by 325
Self-citationSchenk, R., Eggli, P., Fleisch, H., & Rosini, S. (1986) · Calcified Tissue International · doi:10.1007/bf02555748 · Cited by 315
Self-citationA randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
McCloskey, MacLennan, Drayson, Chapman, Dunn, Kanis, & Adults, F. T. M. W. P. O. L. I. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00567.x · Cited by 314
Carano, A., Teitelbaum, S. L., Konsek, J. D., Schlesinger, P. H., & Blair, H. C. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114459 · Cited by 314
Structure-activity relationships of various bisphosphonates
Shinoda, H., Adamek, G., Felix, R., Fleisch, H., Schenk, R., & Hagan, P. (1983) · Calcified Tissue International · doi:10.1007/bf02405012 · Cited by 306
Self-citationBisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
Vitte, C. (1996) · Endocrinology · doi:10.1210/en.137.6.2324 · Cited by 299
Hochberg, M. C., Ross, P. D., Black, D., Cummings, S. R., Genant, H. K., Nevitt, M. C., Barrett-Connor, E., Musliner, T., Thompson, D., & for the Fracture Intervention Trial Research Group (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1246::aid-anr22>3.0.co;2-u · Cited by 287
Pressor Attacks during Treatment with Monoamine-oxidase Inhibitors
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91261-4 · Cited by 286
Rogers, M. J., Watts, D. J., & Russell, R. G. G. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z · Cited by 285
Self-citationAmin, D., Cornell, S., Gustafson, S., Needle, S., Ullrich, J., Bilder, G., & Perrone, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41388-4 · Cited by 281
The Management of Paget's Disease of Bone
Delmas, P. D., & Meunier, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360807 · Cited by 277
Luckman, S. P., Coxon, F. P., Ebetino, F. H., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.11.1668 · Cited by 272
Self-citationEffects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
Sato, M., & Grasser, W. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050107 · Cited by 264
Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones
Masarachia, P., Weinreb, M., Balena, R., & Rodan, G. A. (1996) · Bone · doi:10.1016/8756-3282(96)00182-2 · Cited by 248
Russell, R. G. G., Bisaz, S., Donath, A., Morgan, D. B., & Fleisch, H. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106589 · Cited by 240
Self-citationBM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
Mühlbauer, R. C., Bauss, F., Schenk, R., Janner, M., Bosies, E., Strein, K., & Fleisch, H. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060915 · Cited by 239
Self-citationCharacteristics of clodronate-induced apoptosis in osteoclasts and macrophages.
Selander, K. S., Mönkkönen, J., Karhukorpi, E. K., Härkönen, P., Hannuniemi, R., & Väänänen, H. K. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09541-0 · Cited by 237
Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., & Suda, T. (1995) · Bone · doi:10.1016/s8756-3282(95)00150-6 · Cited by 218
Shipman, C. M., Croucher, P. I., Russell, R. G. G., Helfrich, M. H., & Rogers, M. J. (1998) · PubMed · Cited by 216
Self-citationDIPHOSPHONATES AND PAGET'S DISEASE OF BONE
SMITH (1971) · The Lancet · doi:10.1016/s0140-6736(71)91447-4 · Cited by 203
The Influence of Two Diphosphonates on Calcium Metabolism in the Rat
Gasser, A. B., Morgan, D. B., Fleisch, H. A., & Richelle, L. J. (1972) · Clinical Science · doi:10.1042/cs0430031 · Cited by 202
Self-citationCOMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIA
Ralston, S., Patel, U., Fraser, W., Gallacher, S., Dryburgh, F., Cowan, R., & Boyle, I. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91791-1 · Cited by 195
Flanagan, A. M., & Chambers, T. J. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90021-4 · Cited by 195
van Beek, E., Pieterman, E., Cohen, L., Löwik, C., & Papapoulos, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0224 · Cited by 195
Dr. Rogers, M. J., Chilton, K. M., Coxon, F. P., Lawry, J., Smith, M. O., Suri, S., & Russel, R. G. G. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111015 · Cited by 194
Self-citationSchmidt, A., Rutledge, S. J., Endo, N., Opas, E. E., Tanaka, H., Wesolowski, G., Leu, C. T., Huang, Z., Ramachandaran, C., Rodan, S. B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3068 · Cited by 194
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman, I., Bessent, R. G., Turner, J. G., Citrin, D. L., Boyle, I. T., & Greig, W. R. (1978) · PubMed · Cited by 192
Dr. Löwik, C. W. G. M., Van Der Pluijm, G., Van Der Wee-Pals, L. J. A., Van Treslong-De Groot, H. B., & Bijvoet, O. L. M. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030210 · Cited by 191
Fleisch, H., Russell, R. G. G., Bisaz, S., Casey, P. A., & Mühlbauer, R. C. (1968) · Calcified Tissue Research · doi:10.1007/bf02065192 · Cited by 190
Self-citationEXCRETION OF INORGANIC PYROPHOSPHATE IN HYPOPHOSPHATASIA
RUSSELL, R. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91422-4 · Cited by 178
Self-citationDouglas, D., Graham G, R., Preston, C., Prenton, M., Duckworth, T., Kanis, J., Eric Preston, F., & Stuart Woodhead, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91496-8 · Cited by 177
DIPHOSPHONATES IN PAGET'S DISEASE
Russell, R. G. G., Preston, C., Smith, R., Walton, R. J., & Woods, C. G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90347-x · Cited by 177
Self-citationSauty, A., Pecherstorfer, M., Zimmer-Roth, I., Fioroni, P., Juillerat, L., Markert, M., Ludwig, H., Leuenberger, P., Burckhardt, P., & Thiébaudi, D. (1996) · Bone · doi:10.1016/8756-3282(95)00448-3 · Cited by 176
Zhang, D., Udagawa, N., Nakamura, I., Murakami, H., Saito, S., Yamasaki, K., Shibasaki, Y., Morii, N., Narumiya, S., Takahashi, N., et al. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2285 · Cited by 169
Cyclical Etidronate in the Treatment of Postmenopausal Osteoporosis
Miller, P. D., Watts, N. B., Licata, A. A., Harris, S. T., Genant, H. K., Wasnich, R. D., Ross, P. D., Jackson, R. D., Hoseyni, M. S., Schoenfeld, S., et al. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00278-7 · Cited by 161
Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., & Nagata, N. (1996) · Bone · doi:10.1016/8756-3282(95)00426-2 · Cited by 161
Reitsma, P. H., Bijvoet, O. L. M., Verlinden-Ooms, H., & van der Wee-Pals, L. J. A. (1980) · Calcified Tissue International · doi:10.1007/bf02408534 · Cited by 161
Azuma, Y., Sato, H., Oue, Y., OKABE, K., Ohta, T., Tsuchimoto, M., & Kiyoki, M. (1995) · Bone · doi:10.1016/8756-3282(94)00035-x · Cited by 157
Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study
Siris, E. S., Chines, A. A., Altman, R. D., Brown, J. P., Johnston, C. C., Lang, R., McClung, M. R., Mallette, L. E., Miller, P. D., Ryan, W. G., et al. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.1032 · Cited by 141
Antiresorptive dose-response relationships across three generations of bisphosphonates.
Sietsema, W. K., Ebetino, F. H., Salvagno, A. M., & Bevan, J. A. (1989) · PubMed · Cited by 139
Bisphosphonates as Anticancer Drugs
Mundy, G. R., & Yoneda, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390609 · Cited by 131
Human Osteoclast Formation and Activity In Vitro: Effects of Alendronate
Breuil, V., Cosman, F., Stein, L., Horbert, W., Nieves, J. W., Shen, V., Lindsay, R., & Dempster, D. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.11.1721 · Cited by 122
Fleisch, H. A., Maerki, J., & Russell, R. G. G. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-122-31123 · Cited by 121
Self-citationInhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats.
Schibler, D., Russell, R. G. G., & Fleisch, H. A. (1968) · PubMed · Cited by 121
Self-citationBisphosphonates Are Incorporated into Adenine Nucleotides by Human Aminoacyl-tRNA Synthetase Enzymes
Rogers, M. J., Brown, R. J., Hodkin, V., Blackburn, G. M., Russell, R. G. G., & Watts, D. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1113 · Cited by 115
Self-citationZimolo, Z., Wesolowski, G. A., & Rodan, G. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118283 · Cited by 110
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase
David, P., Nguyen, H., Barbier, A., & Baron, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111017 · Cited by 102
Rogers, M. J., Ji, X., Russell, R. G. G., Blackburn, G. M., Williamson, M. P., Bayless, A. V., Ebetino, F. H., & Watts, D. J. (1994) · Biochemical Journal · doi:10.1042/bj3030303 · Cited by 102
Self-citationMühlbauer, R. C., Russell, R. G. G., Williams, D. A., & Fleisch, H. A. (1971) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1971.tb00640.x · Cited by 99
Self-citationUeber die Einwirkung des Chloracetyls auf phosphorige Säure
Menschutkin, N. (1865) · Justus Liebig s Annalen der Chemie · doi:10.1002/jlac.18651330307 · Cited by 95
van Beek, E. R., Löwik, C. W. G. M., Que, I., & Papapoulos, S. E. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111016 · Cited by 94
The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes
Felix, R., Graham, R., Russell, R. G. G., & Fleisch, H. A. (1976) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(76)90291-6 · Cited by 93
Self-citationUse of cyclical etidronate and prevention of non-vertebral fractures
van Staa, T. P., Abenhaim, L., & Cooper, C. C. (1998) · Rheumatology · doi:10.1093/rheumatology/37.1.87 · Cited by 89
Coxon, F. P., Benford, H. L., Russell, R. G. G., et al. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13063-5 · Cited by 89
Self-citationCoukell, A. J., & Markham, A. (1998) · Drugs & Aging · doi:10.2165/00002512-199812020-00007 · Cited by 82
Facilitation and suppression of bone metastasis.
Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 79
Trechsel, U., Stutzer, A., & Fleisch, H. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113257 · Cited by 74
Self-citationRogers, M. J., Watts, D. J., Russell, R. G. G., Ji, X., Xiong, X., Blackburn, G. M., Bayless, A. V., & Ebetino, F. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090710 · Cited by 73
Self-citationTiludronate inhibits protein tyrosine phosphatase activity in osteoclasts
Murakami, H., Takahashi, N., Tanaka, S., et al. (1997) · Bone · doi:10.1016/s8756-3282(97)00025-2 · Cited by 69
Rogers, M. J., Xiong, X., Ji, X., Mönkkönen, J., Russell, R. G. G., Williamson, M. P., Ebetino, F. H., & Watts, D. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012157212793 · Cited by 68
Self-citationMetabolism of halogenated bisphosphonates by the cellular slime mould dictyostelium discoideum
Rogers, M. J., Russell, R. G. G., Blackburn, G. M., Williamson, M. P., & Watts, D. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91574-a · Cited by 68
Self-citationPapapoulos, S. E., Hoekman, K., Löwik, C. W. G. M., Vermeij, P., & Bijvoet, O. L. M. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040518 · Cited by 67
Risedronate, a Highly Effective Oral Agent in the Treatment of Patients with Severe Paget’s Disease1
Singer, F. R., Clemens, T. L., Eusebio, R. A., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4871 · Cited by 66
Martodam, R. R., Thornton, K. S., Sica, D. A., D'Souza, S. M., Flora, L., & Mundy, G. R. (1983) · Calcified Tissue International · doi:10.1007/bf02405086 · Cited by 61
Human protein tyrosine phosphatase-σ: Alternative splicing and inhibition by bisphosphonates
Endo, N., Rutledge, S. J., Opas, E. E., Vogel, R., Rodan, G. A., & Schmidt, A. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110415 · Cited by 59
Pelorgeas, S., Martin, J., & Satre, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90342-g · Cited by 59
Oral bisphosphonates in the treatment of osteoporosis: a review
Francis, R. M. (1995) · Current Therapeutic Research · doi:10.1016/0011-393x(95)85087-2 · Cited by 57
Russell, R. G. G., & Hodgkinson, A. J. (1966) · PubMed · Cited by 57
Self-citationParamyxoviruses and Paget’s disease: the affirmative view
MEE, A. P. (1999) · Bone · doi:10.1016/s8756-3282(99)00033-2 · Cited by 55
Lerner, U. H., & Larsson, Å. (1987) · Bone · doi:10.1016/8756-3282(87)90018-4 · Cited by 47
Comparison of Cytotoxic Effects of Bisphosphonates In Vitro and In Vivo
Ito, M., Chokki, M., Ogino, Y., SATOMI, Y., Azuma, Y., Ohta, T., & Kiyoki, M. (1998) · Calcified Tissue International · doi:10.1007/s002239900505 · Cited by 44
Yu, X., Schøller, J., & Foged, N. T. (1996) · Bone · doi:10.1016/s8756-3282(96)00184-6 · Cited by 36
Alendronate inhibition of protein-tyrosine-phosphatase-meg1
Opas, E. E., Rutledge, S. J., Golub, E. E., Stern, A. M., Zimoio, Z., Rodan, G. A., & Schmidt, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00225-6 · Cited by 36
Stutzer, A., Fleisch, H. A., & Trechsel, U. (1988) · Calcified Tissue International · doi:10.1007/bf02556639 · Cited by 32
Self-citationRisedronate, a Highly Effective Oral Agent in the Treatment of Patients with Severe Paget's Disease
Singer, F. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1906 · Cited by 32
Cited by
Inorganic pyrophosphate generation and disposition in pathophysiology
Terkeltaub, R. A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.1.c1 · Cited by 484
Managing the care of patients with bisphosphonate-associated osteonecrosis
MIGLIORATI, C. A., CASIGLIA, J., EPSTEIN, J., JACOBSEN, P. L., SIEGEL, M. A., & WOO, S.-B. (2005) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2005.0108 · Cited by 468
A systematic review of the role of bisphosphonates in metastatic disease
Ross, J., Saunders, Y., Edmonds, P., Patel, S., Wonderling, D., Normand, C., & Broadley, K. (2004) · Health Technology Assessment · doi:10.3310/hta8040 · Cited by 467
Bioinorganics and biomaterials: Bone repair
Habibovic, P., & Barralet, J. E. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.03.027 · Cited by 441
Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease
Reid, I. R., Miller, P., Lyles, K., Fraser, W., Brown, J. P., Saidi, Y., Mesenbrink, P., Su, G., Pak, J., Zelenakas, K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044241 · Cited by 439
Metadata
- Authors
- Russell, R. G. G., Rogers, M. J., Frith, J. C., Luckman, S. P., Coxon, F. P., Benford, H. L., Croucher, P. I., Shipman, C., & Fleisch, H. A.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11-01
- Volume
- 14
- Issue
- S2
- Pages
- 53-65
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2024887507
- Cited by
- 279
- References
- 118
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.